Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Physiology of GERD and Treatment Response
NCT04292470Completed
- Sponsor
- University of California, Davis
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of amitriptyline in Functional heartburn (FH), sponsored by University of California, Davis. Primary endpoint: Change in GERD Symptoms at 8 weeks. Started Nov 2020; status: completed.
02
Drugs
amitriptyline
03
Conditions
Functional heartburn (FH)
Beyond the preview
Go deeper on NCT04292470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04292470.